Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Bone Marrow Transplant ; 25(2): 201-3, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10673681

ABSTRACT

The impact of hemodialysis on the clearance of busulfan was determined in a patient with chronic renal failure undergoing autologous peripheral stem cell transplantation for non-Hodgkin's lymphoma. The extraction ratio for busulfan across the dialyzer was 0.530 +/- 0.026 at a blood flow of 400 ml/min, which corresponds to a hemodialysis clearance of 2.23 +/- 0.11 ml/min/kg body weight. Apparent oral clearance of busulfan without hemodialysis was 3.38 +/- 0.56 ml/min/kg. Thus, a 4 h hemodialysis session enhanced the apparent oral clearance of busulfan by 65%. We conclude that hemodialysis effectively removes busulfan from circulating blood, but a standard hemodialysis period (ie, 4 h) does not significantly alter busulfan exposure. Bone Marrow Transplantation(2000) 25, 201-203.


Subject(s)
Busulfan/pharmacokinetics , Kidney Failure, Chronic/metabolism , Lymphoma, Non-Hodgkin/metabolism , Renal Dialysis , Transplantation Conditioning , Administration, Oral , Biological Availability , Blood Transfusion, Autologous , Busulfan/administration & dosage , Busulfan/therapeutic use , Hematopoietic Stem Cell Transplantation , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/physiopathology , Kidney Failure, Chronic/therapy , Lymphoma, Non-Hodgkin/complications , Lymphoma, Non-Hodgkin/therapy , Male , Metabolic Clearance Rate , Middle Aged , Time Factors , Transplantation Conditioning/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...